Kaleido Biosciences Inc (KLDO)
0.00
USD |
OTCM |
Nov 13, 16:00
Kaleido Biosciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2021 | 2.045 |
| September 30, 2021 | 0.7368 |
| June 30, 2021 | 0.4246 |
| March 31, 2021 | 0.2953 |
| Date | Value |
|---|---|
| December 31, 2020 | 1.025 |
| September 30, 2020 | 0.5802 |
| June 30, 2020 | 0.4024 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2953
Minimum
Mar 2021
2.045
Maximum
Dec 2021
0.7871
Average
0.5802
Median
Sep 2020
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 50.14M |
| Total Liabilities (Quarterly) | 39.53M |
| Shareholders Equity (Quarterly) | 10.61M |